Previous close | 2.1900 |
Open | 2.3950 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.2400 - 2.6600 |
52-week range | 2.1050 - 11.7700 |
Volume | |
Avg. volume | 26,480 |
Market cap | 2.624M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -12.9700 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 20.00 |
BERWYN, Pa., April 30, 2024--Virpax Announces Results of MTD Study for Probudur. Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price